Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients

被引:6
作者
Inaba, M
Okuno, S
Chou, H
Imanishi, Y
Ueda, M
Yamakawa, T
Ishimura, E
Nishizawa, Y
机构
[1] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan
[2] Shirasagi Hosp, Higashisumiyoshi Ku, Osaka, Japan
关键词
PTH; bone turnover; bone marker; hemodialysis; chronic renal failure;
D O I
10.1016/j.biopha.2005.11.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To evaluate the usefulness of newly-developed bio-intact parathyroid hormone (Bio-PTH) assay, which measures exclusively intact PTH(184) molecule, serum PTH level determined by Bio-PTH assay, in comparison with second-generation intact PTH (1-PTH) assay, was examined for its correlation with parathyroid gland size. Serum PTH was determined in 46 male HD patients, together with bone formation markers bone alkaline phosphatase, intact osteocalcin, N-terminal propeptide of type I collagen, and bone resorption markers deoxypyridinoline, pyridinoline, beta-crossLaps. Maximal diameter of parathyroid gland was determined with ultrasonography as the parathyroid gland size. Serum Ca and Pi correlated significantly with parathyroid gland size rationalizing our method to define parathyroid gland size. Serum Bio-PTH was correlated significantly in a positive manner with parathyroid gland size (R = 0.308, P = 0.0474), whereas serum I-PTH did not. Furthermore, parathyroid gland size did not exhibit a significant correlation with any of bone formation markers or bone resorption markers. The lack of correlation between bone markers and parathyroid gland size in HD patients may be explained by the occurrence of refractoriness of bone to PTH. In conclusion, serum Bio-PTH assay could provide a better assay than I-PTH assay to estimate parathyroid function in HD patients, due mainly to its exclusive correlation with parathyroid gland size. (c) 2006 Published by Elsevier SAS.
引用
收藏
页码:62 / 65
页数:4
相关论文
共 18 条
  • [1] Dynamics of skeletal resistance to parathyroid hormone in the rat: Effect of renal failure and dietary phosphorus
    Bover, J
    Jara, A
    Trinidad, P
    Rodriguez, M
    Felsenfeld, AJ
    [J]. BONE, 1999, 25 (03) : 279 - 285
  • [2] Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
    Brossard, JH
    Cloutier, M
    Roy, L
    Lepage, R
    GasconBarre, N
    DAmour, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) : 3923 - 3929
  • [3] Brossard JH, 2000, CLIN CHEM, V46, P697
  • [4] Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology
    Fletcher, S
    Jones, RG
    Rayner, HC
    Harden, P
    Hordon, LD
    Aaron, JE
    Oldroyd, B
    Brownjohn, AM
    Turney, JH
    Smith, MA
    [J]. NEPHRON, 1997, 75 (04): : 412 - 419
  • [5] Furumitsu Y, 2000, J RHEUMATOL, V27, P64
  • [6] GOMEZ B, 1995, CLIN CHEM, V41, P1560
  • [7] Significance of Bio-intact PTH(1-84) assay in hemodialysis patients
    Inaba, M
    Okuno, S
    Imanishi, Y
    Ueda, M
    Yamakawa, T
    Ishimura, E
    Nishizawa, Y
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) : 517 - 525
  • [8] Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone
    Inaba, M
    Nakatsuka, K
    Imanishi, Y
    Watanabe, M
    Mamiya, Y
    Ishimura, E
    Nishizawa, Y
    [J]. CLINICAL CHEMISTRY, 2004, 50 (02) : 385 - 390
  • [9] Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus
    Inaba, M
    Nagasue, K
    Okuno, S
    Ueda, M
    Kumeda, Y
    Imanishi, Y
    Shoji, T
    Ishimura, E
    Ohta, T
    Nakatani, T
    Kim, M
    Nishizawa, Y
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) : 1261 - 1269
  • [10] Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes
    Inaba, M
    Nishizawa, Y
    Mita, K
    Kumeda, Y
    Emoto, M
    Kawagishi, T
    Ishimura, E
    Nakatsuka, K
    Shioi, A
    Morii, H
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 9 (06) : 525 - 531